Kawasumi Laboratories Inc. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2017; Provides Earnings Guidance for the Full Year of Fiscal Year Ending March 31, 2018
Kawasumi Laboratories Inc. announced consolidated earnings results for the six months ended September 30, 2017. For the period, the company reported net sales of ¥12,567 million against ¥12,287 million a year ago. Operating profit was ¥342 million against ¥571 million a year ago. Ordinary profit was ¥444 million against ¥467 million a year ago. Profit before income taxes was ¥427 million against ¥465 million a year ago. Profit attributable to owners of parent was ¥313 million against ¥636 million a year ago. Earnings per share were ¥14.37 against ¥29.16 a year ago. Net cash provided by operating activities was ¥1,388 million against ¥1,765 million a year ago. Purchase of property, plant and equipment was ¥420 million against ¥743 million a year ago. Purchase of intangible assets was ¥21 million against ¥120 million a year ago.
For the full year of fiscal year ending March 31, 2018, the company expects consolidated net sales of ¥25,000 million, operating income of ¥650 million, ordinary income of ¥600 million, profit attributable to owners of the parent of ¥600 million or earnings per share of ¥27.50.